Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases

Metabolic syndrome (MetS) is a cluster of metabolic risk factors associated with central obesity, hyperglycemia, insulin resistance, dyslipidemia and high blood pressure. In recent decades, because of the remarkable increase in both prevalence and severity, MetS and its related diseases such as card...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thi Thanh Binh, Jin, Yan Yan, Chung, Hea-Jong, Hong, Seong-Tschool
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151620/
https://www.ncbi.nlm.nih.gov/pubmed/29064399
http://dx.doi.org/10.3390/molecules22101795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151620/
https://www.ncbi.nlm.nih.gov/pubmed/29064399
http://dx.doi.org/10.3390/molecules22101795

Ejemplares similares